These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25178484)

  • 21. Essential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptor.
    Baldys A; Göoz M; Morinelli TA; Lee MH; Raymond JR; Luttrell LM; Raymond JR
    Biochemistry; 2009 Feb; 48(7):1462-73. PubMed ID: 19173594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.
    Ahmad G; Mohapatra BC; Schulte NA; Nadeau SA; Luan H; Zutshi N; Tom E; Ortega-Cava C; Tu C; Sanada M; Ogawa S; Toews ML; Band V; Band H
    Int J Biochem Cell Biol; 2014 Dec; 57():123-34. PubMed ID: 25449262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential parsing of EGFR endocytic flux among parallel internalization pathways in lung cancer cells with EGFR-activating mutations.
    Walsh AM; Lazzara MJ
    Integr Biol (Camb); 2014 Mar; 6(3):312-23. PubMed ID: 24445374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smad7 Modulates Epidermal Growth Factor Receptor Turnover through Sequestration of c-Cbl.
    Ha Thi HT; Kim HY; Choi SW; Kang JM; Kim SJ; Hong S
    Mol Cell Biol; 2015 Aug; 35(16):2841-50. PubMed ID: 26055326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized.
    Padrón D; Sato M; Shay JW; Gazdar AF; Minna JD; Roth MG
    Cancer Res; 2007 Aug; 67(16):7695-702. PubMed ID: 17699773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes.
    Zhang B; Srirangam A; Potter DA; Roman A
    Oncogene; 2005 Apr; 24(15):2585-8. PubMed ID: 15735736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling.
    Martin NP; Mohney RP; Dunn S; Das M; Scappini E; O'Bryan JP
    Mol Pharmacol; 2006 Nov; 70(5):1643-53. PubMed ID: 16914641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell surface epidermal growth factor receptors increase Src and c-Cbl activity and receptor ubiquitylation.
    Parks EE; Ceresa BP
    J Biol Chem; 2014 Sep; 289(37):25537-45. PubMed ID: 25074934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiopoietin-1-induced ubiquitylation of Tie2 by c-Cbl is required for internalization and degradation.
    Wehrle C; Van Slyke P; Dumont DJ
    Biochem J; 2009 Oct; 423(3):375-80. PubMed ID: 19689429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A tale of two Cbls: interplay of c-Cbl and Cbl-b in epidermal growth factor receptor downregulation.
    Pennock S; Wang Z
    Mol Cell Biol; 2008 May; 28(9):3020-37. PubMed ID: 18316398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.
    Aoki Y; Niihori T; Banjo T; Okamoto N; Mizuno S; Kurosawa K; Ogata T; Takada F; Yano M; Ando T; Hoshika T; Barnett C; Ohashi H; Kawame H; Hasegawa T; Okutani T; Nagashima T; Hasegawa S; Funayama R; Nagashima T; Nakayama K; Inoue S; Watanabe Y; Ogura T; Matsubara Y
    Am J Hum Genet; 2013 Jul; 93(1):173-80. PubMed ID: 23791108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intersectin 1 enhances Cbl ubiquitylation of epidermal growth factor receptor through regulation of Sprouty2-Cbl interaction.
    Okur MN; Ooi J; Fong CW; Martinez N; Garcia-Dominguez C; Rojas JM; Guy G; O'Bryan JP
    Mol Cell Biol; 2012 Feb; 32(4):817-25. PubMed ID: 22158968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42.
    Hirsch DS; Shen Y; Wu WJ
    Cancer Res; 2006 Apr; 66(7):3523-30. PubMed ID: 16585176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An attenuated phenotype of Costello syndrome in three unrelated individuals with a HRAS c.179G>A (p.Gly60Asp) mutation correlates with uncommon functional consequences.
    Gripp KW; Sol-Church K; Smpokou P; Graham GE; Stevenson DA; Hanson H; Viskochil DH; Baker LC; Russo B; Gardner N; Stabley DL; Kolbe V; Rosenberger G
    Am J Med Genet A; 2015 Sep; 167A(9):2085-97. PubMed ID: 25914166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Cbl family proteins: ring leaders in regulation of cell signaling.
    Swaminathan G; Tsygankov AY
    J Cell Physiol; 2006 Oct; 209(1):21-43. PubMed ID: 16741904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reciprocal regulation of the ubiquitin ligase Itch and the epidermal growth factor receptor signaling.
    Azakir BA; Angers A
    Cell Signal; 2009 Aug; 21(8):1326-36. PubMed ID: 19341794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia.
    Pérez B; Mechinaud F; Galambrun C; Ben Romdhane N; Isidor B; Philip N; Derain-Court J; Cassinat B; Lachenaud J; Kaltenbach S; Salmon A; Désirée C; Pereira S; Menot ML; Royer N; Fenneteau O; Baruchel A; Chomienne C; Verloes A; Cavé H
    J Med Genet; 2010 Oct; 47(10):686-91. PubMed ID: 20543203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical manifestations of mutations in RAS and related intracellular signal transduction factors.
    Zenker M
    Curr Opin Pediatr; 2011 Aug; 23(4):443-51. PubMed ID: 21750428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase.
    Okur MN; Russo A; O'Bryan JP
    Mol Cell Biol; 2014 Jan; 34(2):271-9. PubMed ID: 24216759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A new "rasopathy": mutation in the CBL tumour-suppressor gene in neuro-cardio-facio-cutaneous syndrome similar to Noonan syndrome].
    Dereure O
    Ann Dermatol Venereol; 2011 Jan; 138(1):75-6. PubMed ID: 21276471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.